On March 3, 2023, CytoDyn Inc. closed the transaction. The company has now received binding subscription agreements to purchase 21.3 million units at a total purchase price of $0.23 per unit for the gross proceeds of $4,899,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2075 USD | +6.41% | +23.44% | +6.41% |
Apr. 15 | CytoDyn Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024 | CI |
Mar. 05 | Transcript : CytoDyn Inc. - Special Call |
1st Jan change | Capi. | |
---|---|---|
+6.41% | 194M | |
+8.63% | 115B | |
+13.17% | 107B | |
-12.76% | 22.31B | |
-3.99% | 21.6B | |
-7.19% | 18.23B | |
-39.93% | 17.62B | |
+6.67% | 14.26B | |
+33.90% | 12.37B | |
-28.60% | 8.28B |
- Stock Market
- Equities
- CYDY Stock
- News CytoDyn Inc.
- CytoDyn Inc. announced that it has received $4.899 million in funding